HIV originated as a virus in primates, crossing into humans through contact with infected animal blood in Central Africa. The best available genetic evidence places the first human infections around the early 1900s, with the virus quietly circulating for decades before anyone knew it existed. The story of how a regional animal virus became a global pandemic involves biology, colonial history, and a series of unlucky amplifying factors.
The Virus Jumped From Primates to Humans
There are two types of HIV, and each came from a different primate. HIV-1, which causes about 95% of all infections worldwide, evolved from a simian immunodeficiency virus (SIV) found in chimpanzees. HIV-2, a less common and generally less aggressive form concentrated in West Africa, came from SIV carried by sooty mangabeys, a type of Old World monkey. Neither virus causes disease in its natural primate host, likely because those animals co-evolved with it over thousands of years. Humans had no such protection.
HIV-1 itself didn’t cross into humans just once. Scientists have identified four distinct groups of HIV-1, labeled M, N, O, and P, each representing a separate spillover event. Groups M and N trace back to chimpanzee SIV, while group O appears to have come from gorillas (who likely caught it from chimpanzees first). Group M is the one that matters most: it’s responsible for the overwhelming majority of AIDS cases on the planet. The other groups remained limited to small clusters in Central Africa. HIV-2 crossed over from sooty mangabeys to humans multiple times as well, producing at least eight separate lineages.
How the Virus Crossed Into Humans
The leading explanation is known as the “cut hunter” hypothesis. For centuries, people in Central Africa hunted and butchered wild primates for food. During that process, a person with an open wound or cut could have been exposed to infected blood. Most of the time, the animal virus probably went nowhere in its new human host. But on rare occasions, the virus adapted enough to replicate in human cells and spread from person to person. This wasn’t one dramatic event. It happened independently at least a dozen times across different primate species, locations, and decades, producing the various groups and types of HIV we see today.
A more controversial theory proposed in the early 1990s suggested that an experimental oral polio vaccine, administered to more than 900,000 people in the Congo, Burundi, and Rwanda between 1957 and 1960, could have been contaminated with SIV from monkey kidney cells used to grow the vaccine. The geography and timing overlapped with what appeared to be the epicenter of the epidemic. However, subsequent testing of archived vaccine samples failed to find SIV contamination, and genetic dating of the virus pushed its origin back well before the 1950s, making this theory unlikely.
Kinshasa: The Epicenter
Genetic analysis points to Kinshasa, the capital of what is now the Democratic Republic of Congo, as the place where HIV first gained a foothold in humans. In the 1920s, the city (then called Leopoldville under Belgian colonial rule) became a kind of perfect storm for viral spread. Its population was growing rapidly as colonial labor demands drew people in from surrounding regions. A roaring sex trade developed. And Belgian-backed railways carried roughly a million people through the city each year, connecting it to a vast network of towns and villages across Central Africa.
Colonial public health campaigns may have made things worse. Mass injection programs for diseases like sleeping sickness and malaria routinely reused needles without sterilization, a practice that could transmit blood-borne viruses with brutal efficiency. The forced labor and population movements imposed on Congolese people during this period created conditions that favored both the initial transfer of SIV from primates to humans and the virus’s subsequent adaptation and spread.
What the Oldest Samples Tell Us
The oldest confirmed HIV sample comes from a Bantu man living in Kinshasa in 1959. A second sample, discovered in a paraffin-preserved lymph node taken from a 28-year-old woman in Kinshasa in 1960, provided a critical breakthrough. Researchers were able to extract only tiny fragments of the virus from her tissue, totaling about one-hundredth of the full genome, but by amplifying those fragments they pieced together enough to compare the two samples.
The 1959 and 1960 viruses differed genetically by 12%, which is a significant gap. Because HIV mutates at a fairly constant rate, scientists could calculate backward: it would have taken roughly 50 years for a single ancestor virus to diversify that much. That math places HIV’s arrival in Kinshasa around 1900 to 1910, consistent with the cut hunter hypothesis and the early colonial disruptions in the Congo Basin.
From Central Africa to the World
For decades, the virus circulated within Central Africa without attracting medical attention. It likely caused scattered, unexplained deaths that were attributed to other causes in a region with limited diagnostic infrastructure. The critical turning point came in the 1960s.
Genetic analysis shows that HIV-1 group M subtype B, the strain that would eventually dominate in the Americas and Europe, moved from Africa to Haiti around 1966. Haiti had connections to the Congo during this period: Haitian professionals had been recruited to work in the newly independent nation. From Haiti, the virus entered the United States in approximately 1969, likely carried by a single individual. The probability that HIV traveled this route, Africa to Haiti to the U.S., is estimated at 99.8%. The alternative hypothesis, that it went directly from Africa to the U.S., has a probability of just 0.003%.
The ancestry of most HIV strains circulating in the United States can be traced to that one introduction event around 1969. For over a decade, the virus spread silently through networks of people who had no reason to suspect a new infectious disease. It wasn’t until 1981 that doctors in Los Angeles and New York noticed unusual clusters of rare pneumonia and skin cancer in otherwise healthy young men, triggering the investigation that would eventually identify HIV and define AIDS.
Why HIV-1 Became a Pandemic and HIV-2 Did Not
HIV-2, despite crossing into humans multiple times from sooty mangabeys in West Africa, never spread globally the way HIV-1 group M did. HIV-2 is harder to transmit sexually, progresses to AIDS more slowly, and maintains a lower level of virus in the blood. Most people with HIV-2 live in West Africa, particularly Guinea-Bissau and Senegal. Even among the eight known HIV-2 lineages, only two (groups A and B) spread significantly among humans. The others appear to have been dead-end transmissions.
HIV-1 group M, by contrast, hit a combination of biological and social conditions that allowed explosive spread. The virus itself replicates aggressively and transmits more easily. And its emergence in a major colonial transit hub, during a period of massive population movement and unsafe medical practices, gave it exactly the infrastructure it needed to move beyond a handful of infected individuals and into the wider world.